Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety.

Cohen F, Aggen JB, Andrews LD, Assar Z, Boggs J, Choi T, Dozzo P, Easterday AN, Haglund CM, Hildebrandt DJ, Holt MC, Joly K, Jubb A, Kamal Z, Kane TR, Konradi AW, Krause KM, Linsell MS, Machajewski TD, Miroshnikova O, Moser HE, Nieto V, Phan T, Plato C, Serio AW, Seroogy J, Shakhmin A, Stein AJ, Sun AD, Sviridov S, Wang Z, Wlasichuk K, Yang W, Zhou X, Zhu H, Cirz RT

Open source

DOI
10.1002/cmdc.201900287
Published
2019 Aug 20
Container
ChemMedChem
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cmdc.201900287,
  title = {Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety.},
  author = {Cohen F and Aggen JB and Andrews LD and Assar Z and Boggs J and Choi T and Dozzo P and Easterday AN and Haglund CM and Hildebrandt DJ and Holt MC and Joly K and Jubb A and Kamal Z and Kane TR and Konradi AW and Krause KM and Linsell MS and Machajewski TD and Miroshnikova O and Moser HE and Nieto V and Phan T and Plato C and Serio AW and Seroogy J and Shakhmin A and Stein AJ and Sun AD and Sviridov S and Wang Z and Wlasichuk K and Yang W and Zhou X and Zhu H and Cirz RT},
  year = {2019},
  journal = {ChemMedChem},
  doi = {10.1002/cmdc.201900287},
  url = {https://doi.org/10.1002/cmdc.201900287}
}

RIS

TY  - JOUR
TI  - Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety.
AU  - Cohen F
AU  - Aggen JB
AU  - Andrews LD
AU  - Assar Z
AU  - Boggs J
AU  - Choi T
AU  - Dozzo P
AU  - Easterday AN
AU  - Haglund CM
AU  - Hildebrandt DJ
AU  - Holt MC
AU  - Joly K
AU  - Jubb A
AU  - Kamal Z
AU  - Kane TR
AU  - Konradi AW
AU  - Krause KM
AU  - Linsell MS
AU  - Machajewski TD
AU  - Miroshnikova O
AU  - Moser HE
AU  - Nieto V
AU  - Phan T
AU  - Plato C
AU  - Serio AW
AU  - Seroogy J
AU  - Shakhmin A
AU  - Stein AJ
AU  - Sun AD
AU  - Sviridov S
AU  - Wang Z
AU  - Wlasichuk K
AU  - Yang W
AU  - Zhou X
AU  - Zhu H
AU  - Cirz RT
PY  - 2019
JO  - ChemMedChem
DO  - 10.1002/cmdc.201900287
UR  - https://doi.org/10.1002/cmdc.201900287
ER  - 

APA

F, C., JB, A., LD, A., Z, A., J, B., T, C., P, D., AN, E., CM, H., DJ, H., MC, H., K, J., A, J., Z, K., TR, K., AW, K., KM, K., MS, L., TD, M., O, M., HE, M., V, N., T, P., C, P., AW, S., J, S., A, S., AJ, S., AD, S., S, S., Z, W., K, W., W, Y., X, Z., H, Z., & RT, C. (2019). Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety.. ChemMedChem. https://doi.org/10.1002/cmdc.201900287

Source records